LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

LLY

1,085.59

+1.84%↑

JNJ

231.35

+0.49%↑

ABBV

215.42

+1.31%↑

UNH

384.08

+1.74%↑

MRK

120.33

+0.58%↑

Home・Elenco Azioni・Medtronic PLC

Search

Medtronic PLC

Aperta

SettoreSettore sanitario

75.91 -2.42

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

75.82

Massimo

78.19

Metriche Chiave
By Trading Economics
Entrata	-231M 1.1B
Vendite	57M 9B
P/E Media del settore	21.598 49.701
EPS	0.89
Rendimento da dividendi	3.72
Margine di Profitto	12.675
Dipendenti	95,000
EBITDA	124M 2.5B

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+35.15% upside

Dividendi
By Dow Jones
Rendimento da dividendi Media del settore	3.72% 2.39%
Utili prossimi	3 giu 2026
Prossima data del Dividendo	10 lug 2026
Prossima data del' Ex Dividendo	26 giu 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-28B 99B
Apertura precedente	78.33
Chiusura precedente	75.91

Notizie sul Sentiment di mercato

By Acuity

24%

76%

45 / 344 Classifica in Healthcare

Medtronic PLC Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

20 mag 2026, 13:49 UTC

Acquisizioni, Fusioni, Takeovers

Medtronic to Buy SPR Therapeutics for About $650 Million

10 mar 2026, 11:19 UTC

Acquisizioni, Fusioni, Takeovers

Medtronic to Buy Scientia Vascular in $550 Million Deal

17 feb 2026, 12:43 UTC

Utili

Medtronic 3Q Profit Falls Despite Higher Revenue

20 mag 2026, 13:15 UTC

Acquisizioni, Fusioni, Takeovers

Medtronic Announces Intent To Acquire SPR Therapeutics, Inc., Expanding Care Options For People Living With Chronic Pain >MDT

20 mag 2026, 13:15 UTC

Acquisizioni, Fusioni, Takeovers

Medtronic to Buy SPR Therapeutics for About $650 Million in Cash >MDT

22 apr 2026, 11:27 UTC

Utili

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

20 apr 2026, 11:50 UTC

Acquisizioni, Fusioni, Takeovers

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

24 mar 2026, 20:59 UTC

Utili

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

10 mar 2026, 10:46 UTC

Acquisizioni, Fusioni, Takeovers

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

10 mar 2026, 10:46 UTC

Acquisizioni, Fusioni, Takeovers

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

10 mar 2026, 10:45 UTC

Acquisizioni, Fusioni, Takeovers

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

10 mar 2026, 10:45 UTC

Acquisizioni, Fusioni, Takeovers

Medtronic to Acquire Scientia Vascular >MDT

17 feb 2026, 21:21 UTC

Utili

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

17 feb 2026, 18:11 UTC

Utili

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb 2026, 14:48 UTC

Utili

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb 2026, 13:00 UTC

Utili

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb 2026, 12:05 UTC

Utili

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 feb 2026, 11:47 UTC

Utili

Medtronic Sees 2026 EPS up 4.5%, Excluding Potential Impact From Tariffs >MDT

17 feb 2026, 11:47 UTC

Utili

Medtronic Still Sees FY26 Organic Revenue Up About 5.5% >MDT

17 feb 2026, 11:46 UTC

Utili

Medtronic FY26 View Includes Potential Impact From Tariffs of About $185M >MDT

17 feb 2026, 11:46 UTC

Utili

Medtronic Backs FY26 View of Adj EPS $5.62-Adj EPS $5.66 >MDT

17 feb 2026, 11:46 UTC

Utili

Medtronic Reiterates FY26 Organic Rev Growth, EPS Guidance >MDT

17 feb 2026, 11:45 UTC

Utili

Medtronic 3Q Adj EPS $1.36 >MDT

17 feb 2026, 11:45 UTC

Utili

Medtronic 3Q Neuroscience Portfolio Rev $2.56B >MDT

17 feb 2026, 11:45 UTC

Utili

Medtronic 3Q Organic Revenue Up 6.0% >MDT

17 feb 2026, 11:45 UTC

Utili

Medtronic 3Q Sales $9.02B >MDT

17 feb 2026, 11:45 UTC

Utili

Medtronic 3Q Diabetes Rev $796M >MDT

17 feb 2026, 11:45 UTC

Utili

Medtronic 3Q Cardiovascular Portfolio Rev $3.46B >MDT

17 feb 2026, 11:45 UTC

Utili

Medtronic 3Q Medical Surgical Portfolio Rev $2.17B >MDT

17 feb 2026, 11:45 UTC

Utili

Medtronic 3Q Net $1.14B >MDT

Confronto tra pari

Modifica del prezzo

Medtronic PLC Previsione

Obiettivo di Prezzo

By TipRanks

35.15% in crescita

Previsioni per 12 mesi

Media 104.88 USD 35.15%

Alto 120 USD

Basso 84 USD

Basato su 18 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Medtronic PLC - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

18 ratings

11

Acquista

7

Mantieni

0

Vendi

Basato sugli analisti di 18 che hanno fornito valutazioni azionarie a Medtronic PLC - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

45 / 344 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Altri titoli del settore

LLY

Eli Lilly and Co.

1,085.59

JNJ

Johnson and Johnson

231.35

ABBV

AbbVie Inc

215.42

UNH

UnitedHealth Group Inc

384.08

MRK

Merck & Co Inc.

120.33

Live chat